Insider · CIK 0001767974

BRADY ANN

Reports to the SEC for 1 company · SOUTH SAN FRANCISCO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001767974

Forms 4 and 5

Insider transactions

15 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2022-02-18	TBPHTheravance Biopharma, Inc.F Tax Payment	PRESIDENT, TBIL	FTax Payment	−8,369 sh	$9.61	−$80.4K	110,319
2021-11-19	TBPHTheravance Biopharma, Inc.F Tax Payment	PRESIDENT, TBIL	FTax Payment	−3,169 sh	$8.36	−$26.5K	118,688
2021-08-20	TBPHTheravance Biopharma, Inc.F Tax Payment	PRESIDENT, TBIL	FTax Payment	−3,169 sh	$14.05	−$44.5K	121,857
2021-05-20	TBPHTheravance Biopharma, Inc.F Tax Payment	PRESIDENT, TBIL	FTax Payment	−3,169 sh	$17.80	−$56.4K	125,026
2021-02-20	TBPHTheravance Biopharma, Inc.F Tax Payment	PRESIDENT, TBIL	FTax Payment	−10.1K sh	$18.79	−$190K	128,195
2021-02-08	TBPHTheravance Biopharma, Inc.A Award	PRESIDENT, TBIL	AAward	+40K sh	—	—	138,287
2020-11-20	TBPHTheravance Biopharma, Inc.F Tax Payment	PRESIDENT, TBIL	FTax Payment	−2,292 sh	$17.21	−$39.4K	98,287
2020-08-20	TBPHTheravance Biopharma, Inc.F Tax Payment	PRESIDENT, TBIL	FTax Payment	−2,292 sh	$18.22	−$41.8K	100,579
2020-05-20	TBPHTheravance Biopharma, Inc.F Tax Payment	PRESIDENT, TBIL	FTax Payment	−2,292 sh	$26.67	−$61.1K	102,871
2020-02-20	TBPHTheravance Biopharma, Inc.F Tax Payment	PRESIDENT, TBIL	FTax Payment	−5,948 sh	$25.90	−$154K	105,163
2020-02-03	TBPHTheravance Biopharma, Inc.A Award	PRESIDENT, TBIL	AAward	+40K sh	—	—	111,111
2019-11-20	TBPHTheravance Biopharma, Inc.F Tax Payment	PRESIDENT, TBIL	FTax Payment	−1,073 sh	$17.60	−$18.9K	71,111
2019-08-20	TBPHTheravance Biopharma, Inc.F Tax Payment	PRESIDENT, TBIL	FTax Payment	−1,073 sh	$21.51	−$23.1K	72,184
2019-05-20	TBPHTheravance Biopharma, Inc.F Tax Payment	PRESIDENT, TBIL	FTax Payment	−1,073 sh	$19.84	−$21.3K	73,257
2019-02-20	TBPHTheravance Biopharma, Inc.F Tax Payment	PRESIDENT, TBIL	FTax Payment	−3,023 sh	$27.00	−$81.6K	74,330

Recent filings

Accepted (ET)
Feb 234
BRADY ANN0001415889-22-001693
SEC(opens sec.gov)
Nov 234
BRADY ANN0001415889-21-005472
SEC(opens sec.gov)
Aug 244
BRADY ANN0001179110-21-008390
SEC(opens sec.gov)
May 244
BRADY ANN0001179110-21-005838
SEC(opens sec.gov)
Feb 234
BRADY ANN0001179110-21-002152
SEC(opens sec.gov)
Feb 104
BRADY ANN0001179110-21-001535
SEC(opens sec.gov)
Nov 244
BRADY ANN0001179110-20-011363
SEC(opens sec.gov)
Aug 244
BRADY ANN0001179110-20-009259
SEC(opens sec.gov)
May 224
BRADY ANN0001179110-20-006521
SEC(opens sec.gov)
Feb 244
BRADY ANN0001179110-20-002141
SEC(opens sec.gov)
Feb 54
BRADY ANN0001179110-20-001196
SEC(opens sec.gov)
Nov 224
BRADY ANN0001179110-19-012011
SEC(opens sec.gov)
Aug 224
BRADY ANN0001179110-19-009783
SEC(opens sec.gov)
May 224
BRADY ANN0001179110-19-006516
SEC(opens sec.gov)
Feb 224
BRADY ANN0001179110-19-002406
SEC(opens sec.gov)

Companies

Theravance Biopharma, Inc.PRESIDENT, TBILTBPH

Address

C/O THERAVANCE BIOPHARMA US, INC. 901 GATEWAY BLVD

SOUTH SAN FRANCISCO, CA, 94080